RMIT scientists in Melbourne have led an international collaboration that potentially unlocks better treatment of viral diseases, including the flu and common cold.
The results were published in the prestigious scientific and medical journal Nature Communications.
Each year the flu virus sends 13,500 Australians to hospital and causes more than 3000 deaths among those aged over 50. The global burden is also staggering, with more than 5 million cases of infection annually with up to 10 per cent resulting in death.
The RMIT senior authors, Dr Stavros Selemidis (ARC Future Fellow) and Dr Eunice To (first author), collaborated with Professor Doug Brooks from University South Australia, Professor John O’Leary from Trinity College Dublin, Monash University’s Professor Christopher Porter, and other scientists and clinicians to investigate how viruses cause disease in humans.
The researchers discovered that a 1.5 billion-year-old cell biological process found in plants, fungi and mammals enhances viral disease in mice and highly likely also in humans. They identified a protein, Nox2 oxidase, that is activated by viruses, including influenza, rhinovirus (the common cold), dengue and HIV.
Once activated, Nox2 oxidase suppresses the body’s key antiviral reaction and its ability to fight and clear the viral infection, which in turn results in a stronger or more virulent disease in mice.
The study also investigated a new prototype drug to treat these debilitating viral diseases.
The researchers found that the Nox2 oxidase protein activated by the viruses is located in a cell compartment called endosomes. They carefully modified a chemical that inhibits or restrains the activity of Nox2 oxidase.
Their customised drug was found to be very effective at suppressing disease caused by influenza infection.
Selemidis, head of the Oxidant and Inflammation Biology Group within the Chronic Infectious and Inflammatory Diseases program at RMIT, said: “Current treatment strategies are limited as they specifically target circulating viruses and have either unknown or very little effect against new viruses that enter the human population.
“We have identified a protein of the immune system that contributes to the disease caused by flu viruses irrespective of their strain.
“We also developed a novel drug delivery system to target this protein, which drastically alleviated the burden of viral disease.
“The strength of this work is the multidisciplinary approach taken and the degree of collaboration. It includes researchers and clinicians from eight universities across Australia, the United States and Ireland.
“This work attracted considerable interest at the NADPH Oxidase GORDON conference in the USA last year.”
To said: “This work identifies a treatment strategy that has the potential to alleviate the symptoms caused by some of the most devastating viruses worldwide, including the flu.”
Learn more: New research points to treatment breakthrough for viruses
The Latest on: Viral diseases
[google_news title=”” keyword=”viral diseases” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]- West Nile virus confirmed in Midland Countyon May 7, 2024 at 2:20 pm
The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.
- West Nile Virus detected in Midland County mosquitoeson May 7, 2024 at 2:13 pm
West Nile Virus confirmed in Midland County for the first time this year. Learn how to protect yourself and your family.
- Bsal and beyond: Task force helps stave off amphibian disease threaton May 7, 2024 at 2:07 pm
Amphibians—like frogs and salamanders—are the most imperiled group of animal species in the world; infectious diseases are among the greatest threats to their existence. After a decade of research, a ...
- Study identifies signifiers of severe COVID-19 disease and deathon May 7, 2024 at 6:48 am
Why do some people with COVID-19 experience little more than a sniffle while others end up on a ventilator? And among critically ill patients, why do some eventually recover while others do not?
- A Fight About Viruses in the Air Is Finally Over. Now It’s Time for Healthy Ventingon May 7, 2024 at 4:00 am
WHO now admits the COVID virus and other germs spread “through the air.” This plain language may help improve research and action to fight disease ...
- Viral Advantage: Prologue Medicines is Here to Release the Viral Proteome’s Therapeutic Potentialon May 7, 2024 at 3:00 am
Prologue Medicines' platform combines computation and high-throughput biology to decode millennia of viral evolution ...
- DHEC advises South Carolinians to get tested for viral hepatitison May 6, 2024 at 10:49 pm
Hepatitis refers to inflammation of the liver. Viral hepatitis is an infectious disease caused by a virus. Hepatitis is what some medical professionals call ‘a hidden illness.’ “A lot of people don’t ...
- Global Veterinary Infectious Disease Diagnostics Market to Witness Exponential Growth, Reaching USD 4.9 Billion by 2033on May 6, 2024 at 8:37 pm
The global veterinary infectious disease diagnostics market is projected to have a high-paced CAGR of 10.1% during the forecast period. The current valuation of the veterinary infectious disease ...
- Gates, Novo Nordisk And Wellcome Commit $300 Million To Climate Change, Infectious Diseases And Nutritionon May 5, 2024 at 9:15 pm
The charitable trifecta — juggernauts of medical funding and philanthropy — warned money and attention for global health problems is drying up around the world and that the world’s poorest will bear ...
- Infectious disease DNA tester Karius nets $100M to expand liquid biopsy reachon May 3, 2024 at 9:18 am
The infectious disease diagnostic developer Karius has secured another $100 million to help expand the reach of its microbial DNA test designed to detect more than 1,000 different pathogens from a | ...
via Google News and Bing News